Several brokerages have updated their recommendations and price targets on shares of OptimizeRx (NASDAQ: OPRX) in the last few weeks:
- 8/14/2026 – OptimizeRx was given a new $11.00 price target by UBS Group AG.
- 8/14/2026 – OptimizeRx had its “market outperform” rating reaffirmed by Citigroup Inc..
- 8/14/2026 – OptimizeRx had its price target raised by Citizens Jmp from $9.00 to $11.00. They now have a “market outperform” rating on the stock.
- 8/13/2026 – OptimizeRx was given a new $12.00 price target by Stifel Nicolaus.
- 8/11/2026 – OptimizeRx had its “sell (d)” rating reaffirmed by Weiss Ratings.
- 7/20/2026 – OptimizeRx was downgraded by Wall Street Zen from “strong-buy” to “buy”.
- 7/12/2026 – OptimizeRx was upgraded by Wall Street Zen from “buy” to “strong-buy”.
OptimizeRx, Inc is a healthcare technology company that operates a digital health network designed to facilitate communication between pharmaceutical manufacturers, payers and healthcare providers. Through its cloud-based platform, OptimizeRx delivers targeted digital interventions—such as patient savings messages, clinical content and product information—directly into electronic health record (EHR) workflows at the point of care. By integrating with leading EHR systems, the company helps life sciences organizations optimize brand engagement, improve patient adherence and support informed prescribing decisions.
The company’s core offerings include digital prescription benefit notifications, co-pay assistance alerts and real-time clinical messaging tailored to specific patient populations.
See Also
- Five stocks we like better than OptimizeRx
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for OptimizeRx Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptimizeRx Corp and related companies with MarketBeat.com's FREE daily email newsletter.
